关于本次交易符合《上市公司监管指引第 9 号——上市公司 筹划和实施重大资产重组的监管要求》第四条规定的说明 西安炬光科技股份有限公司（以下简称"公司"）拟通过全资子公司炬 光（香港）投资管理有限公司以现金方式购买 SÜSS MicroTec SE（SMT） 持有的 SUSS MicroOptic SA（SMO）100.00%股权（以下简称"本次交 易"），可能会达到《重组管理办法》规定的重大资产重组标准，不排除会 构成公司重大资产重组。 公司董事会经审慎判断，认为本次交易符合《上市公司监管指引第 9 号 ——上市公司筹划和实施重大资产重组的监管要求》第四条的规定，具体说 明如下： 本次交易符合《上市公司监管指引第 9 号——上市公司筹划和实施重大 资产重组的监管要求》第四条的规定 （一）本次交易的标的资产为 SMO 100%股权，不涉及立项、环保、行 业准入、用地、规划、建设施工等有关报批事项；就本次交易报批的进展情 况和尚需呈报批准的程序，上市公司已在《西安炬光科技股份有限公司重大 资产购买预案》中详细披露，并对可能无法获得批准或核准的风险作出了特 别提示。 （二）本次交易拟购买资产为 SMO 100%股 ...

西安炬光科技股份有限公司 证券代码：688167 证券简称：炬光科技 公告编号：2023-095 截至 2023 年 10 月 31 日，公司尚未实施股份回购。 三、其他事项 关于以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 回购方案的实施情况：截至 2023 年 10 月 31 日，西安炬光科技股份有限 公司（以下简称"公司"）尚未实施股份回购。 一、回购股份的基本信息 公司分别于 2023 年 8 月 24 日召开第三届董事会第二十一次会议、2023 年 9 月 11 日召开 2023 年第四次临时股东大会，审议通过了《关于以集中竞价交易 方式回购公司股份方案的议案》，同意公司使用不低于人民币 2,520.00 万元、不 超过人民币 5,040.00 万元的首次公开发行普通股取得的超募资金或自有资金，以 不超过人民币 120.00 元/股（含）的价格，通过集中竞价交易方式回购公司股份。 回购期限自股东大会审议通过回购股份方案之日起 12 个月内。 具体内容详见 ...

证券代码：688167 证券简称：炬光科技 西安炬光科技股份有限公司 投资者关系活动记录表 编号：2023-007 投资者关系活动类别 □特定对象调研 □分析师会议 □媒体采访 R 业绩说明会 □新闻发布会 □路演活动 □现场参观 □电话会议 □其他 参与单位名称及人员姓名 见附件 会议时间 2023 年 10 月 30 日 会议地点 西安炬光科技股份有限公司 上市公司接待人员姓名 董事长/总经理：刘兴胜 董事会秘书/市场总监：张雪峰 财务总监：叶一萍 投资者关系活动主要内容 问：公司三季度毛利率相对二季度环比有明显提升，几乎与 | 介绍 | 去年三季度基本持平。请问三季度毛利率提升的原因是什 | | --- | --- | | | 么？以及在目前下游光纤激光器厂家的毛利率和净利率每季 | | | 度环比都在稳步提升的情况下，公司明年上游元器件的价格 | | | 压力是不是会逐渐减弱？ | | | 答：首先，从上游来讲，炬光科技作为光子行业一个元器件 | | | 供应商，公司生产的不管是"产生光子"的半导体激光元器 | | | 件还是"调控光子"的微纳光学元器件，可以应用于很多领 | | | 域，不仅仅是光纤 ...

2023 Third Quarter Report This report presents the unaudited financial results and key operational updates for the third quarter of 2023 [Important Notice](index=1&type=section&id=%E9%87%8D%E8%A6%81%E5%86%85%E5%AE%B9%E6%8F%90%E7%A4%BA) The company's board, supervisory board, and senior management guarantee the truthfulness, accuracy, and completeness of this quarterly report, with financial statements remaining unaudited - This quarter's financial statements are unaudited[6](index=6&type=chunk) [I. Key Financial Data](index=1&type=section&id=%E4%B8%80%E3%80%81%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%95%B0%E6%8D%AE) The company reported a **6.87%** revenue increase in Q3 but significant declines in net profit, while year-to-date revenue decreased by **3.67%** with net profit falling nearly **60%**, alongside a substantial rise in operating cash flow [(I) Key Accounting Data and Financial Indicators](index=1&type=section&id=(%E4%B8%80)%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) In Q3 2023, revenue grew by **6.87%** to **CNY 144.79 million**, but net profit attributable to shareholders declined by **56.13%** to **CNY 16.61 million**, with year-to-date operating cash flow increasing by **109.76%** Key Financial Indicators for Q3 2023 and Year-to-Date | Item | Current Period (Q3) (CNY) | YoY Change (%) (Q3) | Year-to-Date (YTD) (CNY) | YoY Change (%) (YTD) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 144,787,927.06 | 6.87 | 384,469,894.35 | -3.67 | | Net Profit Attributable to Shareholders | 16,613,249.73 | -56.13 | 42,965,288.91 | -59.86 | | Net Profit Attributable to Shareholders, Excluding Non-Recurring Items | 12,236,720.47 | -45.38 | 22,506,454.27 | -67.12 | | Net Cash Flow from Operating Activities | Not applicable | Not applicable | 40,217,728.27 | 109.76 | | Basic Earnings Per Share (CNY/share) | 0.18 | -57.14 | 0.48 | -59.66 | | Diluted Earnings Per Share (CNY/share) | 0.18 | -57.14 | 0.48 | -59.66 | | Weighted Average Return on Net Assets (%) | 0.69 | Decreased 0.88 percentage points | 1.74 | Decreased 2.77 percentage points | | Total R&D Investment (CNY) | 19,918,764.10 | -11.86 | 58,668,254.37 | 3.94 | | R&D Investment as % of Operating Revenue (%) | 13.76 | Decreased 2.92 percentage points | 15.26 | Increased 1.12 percentage points | Key Balance Sheet Indicators | Item | As of Current Period End (2023.09.30) (CNY) | As of Prior Year End (2022.12.31) (CNY) | Change from Prior Year End (%) | | :--- | :--- | :--- | :--- | | Total Assets | 2,637,154,157.96 | 2,707,431,025.19 | -2.60 | | Total Equity Attributable to Shareholders | 2,420,062,684.85 | 2,455,867,733.45 | -1.46 | [(II) Non-Recurring Gains and Losses Items and Amounts](index=2&type=section&id=(%E4%BA%8C)%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%92%8C%E9%87%91%E9%A2%9D) Non-recurring gains and losses totaled **CNY 4.38 million** for the quarter and **CNY 20.46 million** year-to-date, primarily from government grants, fair value changes, and other non-operating income/expenses Non-Recurring Gains and Losses Items and Amounts | Item | Amount for Current Period (CNY) | Amount Year-to-Date (CNY) | | :--- | :--- | :--- | | Gains/Losses on Disposal of Non-Current Assets | | -208,011.12 | | Government Grants Recognized in Current Profit/Loss | | 11,961,313.98 | | Gains/Losses from Fair Value Changes and Investment Income from Disposal of Trading Financial Assets | | 12,443,996.09 | | Other Non-Operating Income and Expenses | 54,401.15 | 2,707.33 | | Gains/Losses from Investments in Associates | -31,962.87 | -44,614.05 | | Less: Income Tax Impact | 775,466.13 | 3,696,557.59 | | Total | 4,376,529.26 | 20,458,834.64 | [(III) Changes in Key Accounting Data, Financial Indicators, and Their Reasons](index=4&type=section&id=(%E4%B8%89)%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E3%80%81%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87%E5%8F%91%E7%94%9F%E5%8F%98%E5%8A%A8%E7%9A%84%E6%83%85%E5%86%B5%E3%80%81%E5%8E%9F%E5%9B%A0) Net profit declined due to increased management and selling expenses, higher credit impairment losses, reduced investment income and government subsidies, and a year-to-date decrease in gross margin from economic downturns and strategic pricing - Reasons for the decline in net profit attributable to shareholders and non-recurring net profit for the current period include: - Increased management expenses: Recognition of share-based payment expenses from restricted stock incentive plans and higher technical service fees for informatization projects[15](index=15&type=chunk) - Increased selling expenses: Higher market expansion costs[15](index=15&type=chunk) - Increased credit impairment losses: Provision for accounts receivable based on prudence principle[15](index=15&type=chunk) - Decreased investment income and government subsidies[15](index=15&type=chunk) - Reasons for the decline in net profit attributable to shareholders and non-recurring net profit year-to-date include: - Decreased gross margin: Impacted by an unfavorable macroeconomic environment in the industrial laser market and strategic price reductions for new pre-fabricated gold-tin aluminum nitride substrate materials to enhance market penetration[15](index=15&type=chunk) - Increased management expenses: Recognition of two periods of equity payment expenses and higher informatization project expenditures[15](index=15&type=chunk) - Increased selling expenses: Higher market expansion costs[15](index=15&type=chunk) - Increased credit impairment losses and decreased investment income and government subsidies[15](index=15&type=chunk) - Reasons for the increase in net cash flow from operating activities year-to-date include: - Reduced payments for purchases and enhanced supplier management, leading to a decrease in cash paid for goods and services[15](index=15&type=chunk) [II. Shareholder Information](index=5&type=section&id=%E4%BA%8C%E3%80%81%E8%82%A1%E4%B8%9C%E4%BF%A1%E6%81%AF) As of the reporting period end, the company had **12,124** common shareholders, with the top ten holding **37.09%**; Liu Xingsheng is the largest shareholder with **13.27%**, acting in concert with Wang Donghui and Xi'an Ningju [(I) Total Number of Common Shareholders, Preferred Shareholders with Restored Voting Rights, and Top Ten Shareholders' Holdings](index=5&type=section&id=(%E4%B8%80)%E6%99%AE%E9%80%9A%E8%82%A1%E8%82%A1%E4%B8%9C%E6%80%BB%E6%95%B0%E5%92%8C%E8%A1%A8%E5%86%B3%E6%9D%83%E6%81%A2%E5%A4%8D%E7%9A%84%E4%BC%98%E5%85%88%E8%82%A1%E8%82%A1%E4%B8%9C%E6%95%B0%E9%87%8F%E5%8F%8A%E5%89%8D%E5%8D%81%E5%90%8D%E8%82%A1%E4%B8%9C%E6%8C%81%E8%82%A1%E6%83%85%E5%86%B5%E8%A1%A8) As of September 30, 2023, the company had **12,124** common shareholders, with Liu Xingsheng as the largest shareholder at **13.27%**, acting in concert with Wang Donghui and Xi'an Ningju Investment - Total number of common shareholders at the end of the reporting period was **12,124**[17](index=17&type=chunk) Top 10 Shareholders' Holdings | Shareholder Name | Shareholder Type | Number of Shares Held | Shareholding Percentage (%) | Number of Restricted Shares Held | | :--- | :--- | :--- | :--- | :--- | | Liu Xingsheng | Domestic Natural Person | 11,994,216 | 13.27 | 11,953,376 | | Wang Donghui | Domestic Natural Person | 5,969,128 | 6.61 | 5,969,128 | | Xi'an High-tech Industrial Venture Capital Co., Ltd. – Shaanxi Integrated Circuit Industry Investment Fund (Limited Partnership) | Other | 3,756,193 | 4.16 | 0 | | Xi'an Institute of Optics and Precision Mechanics of CAS Investment Holding Co., Ltd. | State-owned Legal Entity | 2,707,637 | 3.00 | 0 | | Shenzhen Nanshan Jiaqiao Excellence Intelligent Equipment Investment Partnership (Limited Partnership) | Other | 2,360,000 | 2.61 | 0 | | Shenzhen Chang'an Huifu Venture Capital Enterprise (Limited Partnership) | Other | 2,048,853 | 2.27 | 0 | | Zhang Tong | Domestic Natural Person | 2,001,200 | 2.21 | 0 | | Hubble Technology Venture Capital Co., Ltd. | Domestic Non-state-owned Legal Entity | 2,000,000 | 2.21 | 0 | | Ma Xuanheng | Domestic Natural Person | 1,894,749 | 2.10 | 0 | | Xi'an Ningju Investment Limited Partnership | Other | 1,762,852 | 1.95 | 1,762,852 | - Shareholder Liu Xingsheng, Wang Donghui, and Xi'an Ningju Investment Limited Partnership are parties acting in concert[19](index=19&type=chunk) [III. Other Reminders](index=7&type=section&id=%E4%B8%89%E3%80%81%E5%85%B6%E4%BB%96%E6%8F%90%E9%86%92%E4%BA%8B%E9%A1%B9) The company partnered with Company B on lidar emitter modules, transferring R&D results and authorizing self-production, and approved a share repurchase plan that remains unimplemented as of the reporting period end [1. Lidar Emitter Module Collaboration](index=7&type=section&id=1.%E8%BF%91%E6%9C%9F%EF%BC%8C%E5%85%AC%E5%8F%B8%E5%92%8C%20B%20%E5%85%AC%E5%8F%B8%E5%B0%B1%E6%BF%80%E5%85%89%E9%9B%B7%E8%BE%BE%E5%8F%91%E5%B0%84%E6%A8%A1%E7%BB%84%E5%90%88%E4%BD%9C%E8%BE%BE%E6%88%90%E4%B8%80%E8%87%B4) The company reached an agreement with Company B for lidar emitter module collaboration, transferring prior R&D service results and authorizing Company B to self-produce the modules - The company and Company B reached an agreement on lidar emitter module collaboration, with Juguang Technology agreeing to transfer prior R&D service results and authorize Company B to self-produce the lidar emitter modules[21](index=21&type=chunk) [2. Share Repurchase Status](index=7&type=section&id=2.%E8%82%A1%E4%BB%BD%E5%9B%9E%E8%B4%AD%E6%83%85%E5%86%B5%E8%AF%B4%E6%98%8E) Shareholders approved a plan to repurchase shares via centralized bidding within 12 months, with an amount between **CNY 25.2 million** and **CNY 50.4 million** at a price not exceeding **CNY 120/share**, though no repurchases have occurred as of September 30, 2023 - The company approved a share repurchase plan, intending to use over-raised funds or own funds of no less than **CNY 25.20 million** and no more than **CNY 50.40 million** to repurchase shares at a price not exceeding **CNY 120.00/share** (inclusive)[22](index=22&type=chunk) - The repurchase period is within 12 months from the date the share repurchase plan was approved by the general meeting of shareholders[22](index=22&type=chunk) - As of September 30, 2023, the company has not yet implemented the share repurchase[23](index=23&type=chunk) [IV. Quarterly Financial Statements](index=7&type=section&id=%E5%9B%9B%E3%80%81%E5%AD%A3%E5%BA%A6%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) This section presents the company's unaudited consolidated balance sheet, income statement, and cash flow statement for Q3 2023, reflecting financial position, operating results, and cash flows for the first three quarters [(I) Type of Audit Opinion](index=7&type=section&id=(%E4%B8%80)%E5%AE%A1%E8%AE%A1%E6%84%8F%E8%A7%81%E7%B1%BB%E5%9E%8B) This quarter's financial statements are unaudited - This quarter's financial statements are unaudited[24](index=24&type=chunk) [Consolidated Balance Sheet](index=7&type=section&id=%E5%90%88%E5%B9%B6%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8) As of September 30, 2023, total assets were **CNY 2.64 billion**, down **2.60%** from year-end, with trading financial assets decreasing **68.04%** and cash increasing **38.06%**, while total liabilities decreased **13.70%** Consolidated Balance Sheet Key Data (September 30, 2023 vs December 31, 2022) | Item | September 30, 2023 (CNY) | December 31, 2022 (CNY) | Change (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | **Assets** | | | | | | Cash and Cash Equivalents | 1,338,087,100.73 | 969,194,635.04 | 368,892,465.69 | 38.06 | | Trading Financial Assets | 235,670,850.04 | 737,349,255.93 | -501,678,405.89 | -68.04 | | Accounts Receivable | 176,674,977.57 | 148,334,638.37 | 28,340,339.20 | 19.11 | | Inventories | 234,673,238.03 | 243,487,920.97 | -8,814,682.94 | -3.62 | | Total Current Assets | 2,049,927,858.70 | 2,190,844,805.29 | -140,916,946.59 | -6.43 | | Fixed Assets | 300,166,281.13 | 295,056,950.01 | 5,109,331.12 | 1.73 | | Construction in Progress | 95,687,093.71 | 50,058,598.65 | 45,628,495.06 | 91.15 | | Intangible Assets | 47,418,420.55 | 40,007,326.43 | 7,411,094.12 | 18.52 | | Total Non-Current Assets | 587,226,299.26 | 516,586,219.90 | 70,640,079.36 | 13.67 | | **Total Assets** | **2,637,154,157.96** | **2,707,431,025.19** | **-70,276,867.23** | **-2.60** | | **Liabilities** | | | | | | Short-term Borrowings | 41,110,000.00 | 54,418,590.63 | -13,308,590.63 | -24.46 | | Accounts Payable | 34,111,653.33 | 61,418,548.45 | -27,306,895.12 | -44.46 | | Contract Liabilities | 19,909,712.34 | 9,811,106.94 | 10,098,605.40 | 102.93 | | Total Current Liabilities | 155,739,171.22 | 209,480,002.76 | -53,740,831.54 | -25.65 | | Long-term Borrowings | 21,480,000.00 | 0 | 21,480,000.00 | N/A | | Total Non-Current Liabilities | 61,352,301.89 | 42,083,288.98 | 19,269,012.91 | 45.79 | | **Total Liabilities** | **217,091,473.11** | **251,563,291.74** | **-34,471,818.63** | **-13.70** | | **Shareholders' Equity** | | | | | | Paid-in Capital (or Share Capital) | 90,363,344.00 | 89,960,000.00 | 403,344.00 | 0.45 | | Capital Reserve | 2,278,042,328.97 | 2,241,757,783.19 | 36,284,545.78 | 1.62 | | Less: Treasury Stock | 80,165,943.64 | 0 | 80,165,943.64 | N/A | | Total Equity Attributable to Parent Company Shareholders | 2,420,062,684.85 | 2,455,867,733.45 | -35,805,048.60 | -1.46 | | **Total Shareholders' Equity** | **2,420,062,684.85** | **2,455,867,733.45** | **-35,805,048.60** | **-1.46** | [Consolidated Income Statement](index=10&type=section&id=%E5%90%88%E5%B9%B6%E5%88%A9%E6%B6%A6%E8%A1%A8) For the first three quarters of 2023, total operating revenue was **CNY 384.47 million**, down **3.67%**, with operating profit and net profit declining **65.33%** and **59.57%** respectively, driven by increased costs and expenses, and reduced other income Consolidated Income Statement Key Data (First Three Quarters 2023 vs First Three Quarters 2022) | Item | First Three Quarters 2023 (Jan-Sep) (CNY) | First Three Quarters 2022 (Jan-Sep) (CNY) | Change (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Total Operating Revenue | 384,469,894.35 | 399,127,574.00 | -14,657,679.65 | -3.67 | | Total Operating Costs | 340,269,581.37 | 299,062,409.62 | 41,207,171.75 | 13.78 | | Of which: Operating Costs | 201,942,451.82 | 177,350,640.36 | 24,591,811.46 | 13.87 | | Selling Expenses | 31,873,798.38 | 23,935,883.41 | 7,937,914.97 | 33.16 | | Administrative Expenses | 76,994,025.41 | 57,659,643.07 | 19,334,382.34 | 33.53 | | R&D Expenses | 58,668,254.37 | 56,444,800.51 | 2,223,453.86 | 3.94 | | Financial Expenses | -32,225,381.43 | -17,879,265.34 | -14,346,116.09 | 80.24 | | Other Income | 7,961,313.98 | 14,837,967.40 | -6,876,653.42 | -46.35 | | Gains from Fair Value Changes | 12,443,996.09 | 21,153,079.33 | -8,709,083.24 | -41.17 | | Credit Impairment Losses | -11,325,059.75 | -7,275,205.58 | -4,049,854.17 | 55.67 | | Operating Profit | 39,864,712.61 | 114,953,443.95 | -75,088,731.34 | -65.33 | | Total Profit | 43,590,515.25 | 124,113,517.53 | -80,523,002.28 | -64.88 | | Net Profit | 42,965,288.91 | 106,273,813.69 | -63,308,524.78 | -59.57 | | Net Profit Attributable to Parent Company Shareholders | 42,965,288.91 | 107,030,069.46 | -64,064,780.55 | -59.86 | | Basic Earnings Per Share (CNY/share) | 0.48 | 1.19 | -0.71 | -59.66 | [Consolidated Cash Flow Statement](index=12&type=section&id=%E5%90%88%E5%B9%B6%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8) In the first three quarters of 2023, net cash flow from operating activities increased by **109.76%** to **CNY 40.22 million**, while net cash flow from investing activities turned positive at **CNY 424.76 million** due to increased investment recovery, and financing activities turned negative at **CNY -81.66 million** Consolidated Cash Flow Statement Key Data (First Three Quarters 2023 vs First Three Quarters 2022) | Item | First Three Quarters 2023 (Jan-Sep) (CNY) | First Three Quarters 2022 (Jan-Sep) (CNY) | Change (CNY) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 40,217,728.27 | 19,173,291.24 | 21,044,437.03 | 109.76 | | Net Cash Flow from Investing Activities | 424,764,932.83 | -839,296,625.28 | 1,264,061,558.11 | 150.61 | | Net Cash Flow from Financing Activities | -81,657,908.05 | 6,541,785.39 | -88,199,693.44 | -1348.25 | | Effect of Exchange Rate Changes on Cash and Cash Equivalents | 3,255,160.87 | 613,726.57 | 2,641,434.30 | 430.41 | | Net Increase in Cash and Cash Equivalents | 386,579,913.92 | -812,967,822.08 | 1,199,547,736.00 | 147.55 | | Cash and Cash Equivalents at Period End | 1,307,943,452.94 | 932,056,988.64 | 375,886,464.30 | 40.33 | - Total cash inflows from operating activities were **CNY 427 million**, with total outflows of **CNY 387 million**[36](index=36&type=chunk) - Total cash inflows from investing activities were **CNY 1.79 billion**, with total outflows of **CNY 1.37 billion**, primarily influenced by cash received from investment recovery and cash paid for investments[37](index=37&type=chunk)

证券代码：688167 证券简称：炬光科技 公告编号：2023-094 西安炬光科技股份有限公司 股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 2023 年 10 月 26 日，公司收到国投高科出具的《股份减持计划实施结果告 知函》，本次减持计划时间区间届满，在本次减持计划期间，国投高科通过集中 竞价交易方式累计减持公司股份 1,200,400 股，累计减持比例占公司总股本的 1.3284%。现将减持计划的实施结果情况公告如下： 注：上表"持股比例"以减持计划披露时公司总股本 89,960,000 股计算而得。 上述减持主体无一致行动人。 1 股东名称 股东身份 持股数量（股） 持股比例 当前持股股份来源 国投高科 5%以下股东 2,480,974 2.7579% IPO 前取得：2,480,974 股 一、减持主体减持前基本情况 二、减持计划的实施结果 （一）股东因以下事项披露减持计划实施结果： 重要内容提示： 股东持股的基本情况 本次减持计划实施前，国投高科技投资有限公司（以下简称" ...

证券代码：688167 证券简称：炬光科技 公告编号：2023-093 西安炬光科技股份有限公司 关于召开 2023 年第三季度业绩说明会的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 西安炬光科技股份有限公司（以下简称"公司"）将于 2023 年 10 月 28 日 在上海证券交易所网站（www.sse.com.cn）披露公司《2023 年第三季度报告》。 为便于广大投资者更加全面深入地了解公司发展战略、经营业绩等情况，公司定 于 2023 年 10 月 30 日（星期一）15:00-16:30 召开公司 2023 年第三季度业绩说 明会，就投资者关心的问题进行沟通和交流，广泛听取投资者的意见和建议。具 体如下： 参与本次业绩说明会： 1、电脑端参会：https://s.comein.cn/Af3vx 一、说明会类型 本次业绩说明会以电话会议方式召开，公司将就 2023 年截至第三季度的经 营情况与投资者进行互动交流和沟通，在信息披露允许的范围内就投资者普遍关 注的问题进行回答。 二、公司参会人员 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 回购方案的实施情况：截至 2023 年 9 月 30 日，西安炬光科技股份有限 公司（以下简称"公司"）尚未实施股份回购。 一、回购股份的基本信息 证券代码：688167 证券简称：炬光科技 公告编号：2023-092 西安炬光科技股份有限公司 关于以集中竞价交易方式回购公司股份的进展公告 截至 2023 年 9 月 30 日，公司尚未实施股份回购。 三、其他事项 公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律 1 监管指引第 7 号——回购股份》等相关规定及公司回购股份方案，在回购期限内 根据市场情况择机做出回购决策并予以实施，并根据回购股份事项进展情况及时 履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 西安炬光科技股份有限公司董事会 公司分别于 2023 年 8 月 24 日召开第三届董事会第二十一次会议、2023 年 9 月 11 日召开 2023 年第四次临时股东大会，审议通过了《关于以集中竞价交易 方式回购公司股份方 ...

证券代码：688167 证券简称：炬光科技 公告编号：2023-091 西安炬光科技股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次上市流通的限售股数量为 2,800,000 股，不涉及战略配售股份。 本次上市流通日期为 2023 年 9 月 25 日（因 2023 年 9 月 23 日为非交易 日，故顺延至下一交易日）。 一、 本次上市流通的限售股类型 中国证券监督管理委员会于 2021 年 11 月 23 日发布《关于同意西安炬光科 技股份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕3640 号）， 同意公司向社会首次公开发行人民币普通股（A 股）22,490,000 股，并于 2021 年 12 月 24 日在上海证券交易所科创板上市交易。 1 89,960,000 股增加至 90,363,344 股，本次上市流通的限售股占股本总数的比例由 3.11%变为 3.10%。 三、 本次上市流通的限售股的有关承诺 根据公司《首次公开发行股票 ...

本次上市流通的限售股为公司首次公开发行部分限售股，共涉及 2 名股东， 解除限售股并申请上市流通股份数量为 2,800,000 股，占公司当前总股本的 3.10%。 该部分限售股限售期为自公司完成当次增资扩股工商变更登记手续之日即 2020 年 9 月 23 日起 36 个月，现锁定期即将届满，将于 2023 年 9 月 25 日起上市流 通。 二、本次上市流通的限售股形成后至今公司股本数量变化情况 本次上市流通的限售股属于首次公开发行限售股，自公司首次公开发行股票 限售股形成至本核查意见出具之日，公司未发生因利润分配、公积金转增等导致 股本数量变化的情况。公司因限制性股票激励计划限制性股票归属导致公司股本 总数由 89,960,000 股增加至 90,363,344 股，本次上市流通的限售股占股本总数的 比例由 3.11%变为 3.10%。 三、本次上市流通的限售股的有关承诺 中信建投证券股份有限公司 关于西安炬光科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"或"保荐人"）作 为西安炬光科技股份有限公司（以下简称"炬光科技"或"公司"）首次公开 ...

西安炬光科技股份有限公司 第三届监事会第十九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 证券代码：688167 证券简称：炬光科技 公告编号：2023-090 具体内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）及指 定媒体的《西安炬光科技股份有限公司关于增加使用暂时闲置自有资金进行现金 管理额度的公告》（公告编号：2023-089）。 特此公告。 1 西安炬光科技股份有限公司监事会 西安炬光科技股份有限公司（以下简称"公司"）于 2023 年 9 月 15 日以现场 与通讯相结合的方式召开了第三届监事会第十九次会议。本次会议通知于 2023 年 9 月 10 日以电子邮件的方式送达全体监事。本次会议由公司监事会主席张晖 先生召集并主持，会议应出席监事 5 名，实际出席监事 5 名，本次会议的召集、 召开程序和方式符合《中华人民共和国公司法》等法律法规以及《西安炬光科技 股份有限公司章程》的有关规定，会议决议合法、有效。 二、监事会会议审议情况 会议经与会 ...